CD8A and neoplasm: Specifically, antigen-capturing nanoparticles (AC-NPs) can deliver tumor-specific proteins to APCs and significantly improve the efficacy of αPD-1 treatment and induce an expansion of CD8+ cytotoxic T cells and increased both CD4+T/Treg and CD8+T/Treg ratios (116).